Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Hlavní autor: | Shawn, Ibna Hasan |
---|---|
Další autoři: | Jamiruddin, Mohd. Raeed |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
Brac University
2024
|
Témata: | |
On-line přístup: | http://hdl.handle.net/10361/23931 |
Podobné jednotky
-
A review on Metastatic Melanoma combination therapy Ipilimumab-Nivolumab
Autor: Chakraborty, Anupama
Vydáno: (2024) -
Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
Autor: Onanna, Kazi
Vydáno: (2024) -
Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
Autor: Rahman, Towsifur
Vydáno: (2024) -
A review on combinatorial therapies in Melanoma
Autor: Ahmmed, Md. Kawsar
Vydáno: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
Autor: Khandker, Tahia Anjum
Vydáno: (2024)